sectors
Health Care
UnitedHealth Group and AbbVie illustrate why health care cannot be assessed with one revenue-quality assumption. Premium and service revenue have a different cost structure from prescription-medicine revenue, and acquired research charges require specific accounting context. Coverage in this edition: UnitedHealth Group Incorporated (UNH), AbbVie Inc. (ABBV). Reading approach Keep reported EPS, adjusted EPS, product revenue and medical or research costs in their respective definitions. Do not turn large revenue into a prediction of shareholder returns. Comparison limits Reimbursement, medical utilization, product exclusivity, clinical development and acquired intangible assets create different exposures. Two issuer cases do not yield a sector-wide margin. Classification note Sector names are editorial research groupings for this website, not a licensed or issuer-confirmed classification. Figures, dates and source links are provided on the company and report pages.
Benefits administration and biopharmaceutical sales: Reported FY2025 Results →